The size of the Electrophoresis Market in North America is predicted at USD 0.90 Billion in 2022 and will grow USD 1.16 billion by 2027. This market is growing at a CAGR of 5.05% from 2022 to 2027. North America is the leading region in the global market. The growing number of cancer cases and increasing usage of capillary electrophoresis with mass spectroscopy primarily drive the market growth of this region.
Electrophoresis is used as immune-electrophoresis, which can be used to detect specific proteins like immunoglobulins, which act as antibodies. These are part of the body’s immune system and protect from foreign proteins. Analyzing these antibodies helps design new therapies to treat these threats and provides insight into conditions like allergies and autoimmune disorders. Electrophoresis is the motion of dispersed particles relative to a fluid influenced under a uniform electric field applied spatially.
The primary factors accounted for the growth of the market are rising to fund electrophoresis techniques, increasing incidences of chronic diseases, cancer and genetic disorders, growing focus on next-generation sequencing (NGS). The growing number of industry-academia research collaborations and increasing funding for research on genomic and proteomic techniques will also support the growth of the market.
On the other hand, electrophoresis techniques are time-consuming operations and offer limited sample analysis, and the presence of alternative technologies to electrophoresis may curb the growth of the market.
This research report segmented and sub-segmented the North America Electrophoresis Market into the following categories:
Based on the region, The United States is leading the North American market while Canada is second. The growing focus of stakeholders on research projects involving proteins, associated biomolecules, and genes has helped the U.S. dominate the market. The United States is also expected to grow the fastest due to increasing research funding, growing proteomics and genomics techniques and rising adoption of advanced electrophoresis techniques.
The electrophoresis market of Canada was in second place in the North American Electrophoresis market in 2019. Factors such as increasing occurrence rate of cancer, infectious diseases, and genetic disorders propelling the market. However, the installation and maintenance of the equipment are so expensive, and variations in economic strategies within a short period restrict the market growth in this region.
Promising Companies dominating this North America Electrophoresis Market Profiled in the Report are Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies, Merck Millipore, PerkinElmer, QIAGEN N.V., Lonza Group Ltd., Shimadzu Corporation, Harvard Bioscience, Serbia Group, and C.B.S. Scientific Company.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org